Graticule Asia Macro Advisors LLC Rocket Pharmaceuticals, Inc. Transaction History

Graticule Asia Macro Advisors LLC

  • $0
  • Q4 2023

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021
SELL
$39.41 - $47.25 $985,249 - $1.18 Million
-25,000 Closed
0 $0
Q1 2021

May 17, 2021
SELL
$43.34 - $65.91 $467,638 - $711,168
-10,790 Reduced 30.15%
25,000 $1.11 Million
Q4 2020

Feb 16, 2021
BUY
$23.3 - $59.57 $833,907 - $2.13 Million
35,790 New
35,790 $1.96 Million

Others Institutions Holding RCKT

# of Institutions
209
Shares Held
93.2M
Call Options Held
319K
Put Options Held
70.3K
View Full List

About ROCKET PHARMACEUTICALS, INC.

RCKT Quotes by TradingView
  • Ticker RCKT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 75,683,696
  • Market Cap $1.07B
  • Description
  • Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...
More about RCKT
Track This Portfolio

Track Graticule Asia Macro Advisors LLC Portfolio

Follow Graticule Asia Macro Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Graticule Asia Macro Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Graticule Asia Macro Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email